Air Canada
AC
BCE Inc
BCE
Enbridge Inc
ENB
4
GoldMining Inc
GOLD
5
WELL Health Technologies Corp
WELL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 44.37%-1.35M | -375.63K | 66.97%-377.21K | 93.27%-84.01K | -514.15K | -7.41%-2.43M | -451.05%-1.14M | -173.19%-1.25M | 54.77%-534.71K | -105.72%-2.26M |
Net income from continuing operations | -972.46%-35.79M | ---868.66K | -19,307.26%-33.91M | -215.28%-460.96K | ---558.82K | 4.09%-3.34M | 114.13%176.52K | -6.46%-146.21K | -34.36%-1.61M | -373.57%-3.48M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | --1.11K | --1.54K | ---78 | --1.18K | ---- |
Depreciation and amortization | -20.03%3.16K | --124 | --449 | --1.01K | --1.58K | --3.95K | ---- | ---- | ---- | --0 |
Asset impairment expenditure | --33.24M | --486.89K | ---- | ---- | ---- | --0 | ---- | ---- | ---- | 634.51%1.21M |
Remuneration paid in stock | -71.86%531.67K | --95.04K | 68.07%295.52K | -52.12%87.78K | --53.34K | 380.68%1.89M | 154.66%175.83K | 165.52%183.33K | 365.46%871.66K | 1,690.54%393.13K |
Deferred tax | --0 | --0 | --13K | ---102K | --89K | --51K | ---- | ---- | ---- | --0 |
Other non cashItems | 137.88%508.88K | --0 | ---- | ---- | ---- | ---1.34M | ---895.43K | ---535.43K | ---38.5K | ---- |
Change In working capital | -47.16%161.98K | ---89.03K | 94.01%-39.91K | 152.07%390.17K | ---99.25K | 180.22%306.54K | -1,140.84%-666.45K | -92.90%-749.31K | 241.38%241.41K | 30.62%-382.1K |
-Change in receivables | -56.50%205.96K | --49.06K | 98.59%-5.81K | 206.45%112.19K | --50.52K | 624.03%473.44K | -2,970.07%-412.19K | -943.98%-105.39K | 182.41%36.62K | -1,514.19%-90.35K |
-Change in prepaid assets | 159.95%73.56K | ---4.43K | 219.78%2.56K | 103.80%15.26K | --60.16K | 59.83%-122.7K | -119.07%-2.14K | -2,377.84%-401.63K | 84.78%-47.59K | 59.88%-305.46K |
-Change in payables and accrued expense | -984.22%-117.54K | ---133.66K | -155.94%-36.67K | 251.15%262.72K | ---209.93K | -3.00%13.29K | -121.63%-14.33K | 52.00%-173.82K | 35.39%252.37K | -93.66%13.7K |
-Change in other current assets | --0 | --0 | --0 | ---- | ---- | ---57.5K | ---- | ---- | ---- | --0 |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---180.3K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 44.37%-1.35M | ---375.63K | 66.97%-377.21K | 93.27%-84.01K | ---514.15K | -7.41%-2.43M | -451.05%-1.14M | -173.19%-1.25M | 54.77%-534.71K | -105.72%-2.26M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 54.27%-2.84M | -238.56K | 82.77%-515.79K | 29.62%-904.86K | -1.18M | -5,547.20%-6.21M | -2.99M | -1,068.96%-1.29M | 2.46M | -193.31%-109.99K |
Net PPE purchase and sale | 37.13%-12.3K | --0 | --0 | --0 | ---12.3K | ---19.56K | ---- | ---- | ---- | --0 |
Net business purchase and sale | --0 | ---- | ---- | ---- | --0 | --2.65M | --0 | ---250.7K | --2.65M | --0 |
Net other investing changes | 68.03%-2.83M | ---238.56K | 82.70%-515.79K | 12.58%-904.86K | ---1.17M | -7,941.45%-8.84M | ---2.98M | ---1.04M | ---190.2K | -193.31%-109.99K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 54.27%-2.84M | ---238.56K | 82.77%-515.79K | 29.62%-904.86K | ---1.18M | -5,547.20%-6.21M | ---2.99M | -1,068.96%-1.29M | --2.46M | -193.31%-109.99K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -80.62%2.19M | 0 | 0 | 155,244.33%2.19M | 0 | 509.98%11.3M | -100.00%-1 | -100.20%-1.41K | 775.06%9.39M | 12.27%1.85M |
Net common stock issuance | -81.38%2.28M | --0 | --0 | ---- | ---- | 1,039.44%12.22M | --3.18M | ---3.18M | 849.42%10.18M | -6.58%1.07M |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | -99.74%2K | -4,343.33%-3.18M | 351.10%3.18M | --2K | 550.42%780.5K |
Net other financing activities | 90.83%-84.36K | --0 | --0 | ---- | ---- | ---919.53K | ---1 | ---1.41K | ---799.48K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -80.62%2.19M | --0 | --0 | 155,244.33%2.19M | --0 | 509.98%11.3M | -100.00%-1 | -100.20%-1.41K | 775.06%9.39M | 12.27%1.85M |
Net cash flow | ||||||||||
Beginning cash position | 1,248.83%2.88M | --1.49M | -73.50%2.38M | -89.75%1.18M | --2.88M | -70.84%213.23K | 1,082.24%8.99M | 1,753.83%11.53M | -70.84%213.23K | 236.27%731.35K |
Current changes in cash | -175.13%-2M | ---614.19K | 78.41%-893K | 147.41%1.2M | ---1.7M | 613.96%2.66M | -3,026.80%-4.14M | -1,926.42%-2.53M | 10,423.51%11.31M | -200.83%-518.12K |
End cash Position | -69.56%875.56K | --875.56K | -69.32%1.49M | -73.50%2.38M | --1.18M | 1,248.83%2.88M | 672.88%4.86M | 1,082.24%8.99M | 1,753.83%11.53M | -70.84%213.23K |
Free cash from | 44.32%-1.36M | ---375.63K | 67.31%-377.21K | 93.27%-84.01K | ---526.45K | -8.28%-2.45M | -456.72%-1.15M | -173.19%-1.25M | 54.77%-534.71K | -105.72%-2.26M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | Unqualified Opinion with Explanatory Notes |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.